Comparison of the Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and Caucasian Patients With Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia
ConclusionThese results suggest that mutational analysis is invaluable for choosing an appropriate second-line TKI in Asia.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Clinical Trials | Gleevec | Leukemia | Lymphoma | Myeloma | Nilotinib | Study | Tasigna